69 related articles for article (PubMed ID: 1509607)
21. Anti-hypertensive drug utilization in Continental Portugal (1999-2004).
Furtado C; Pinto M
Rev Port Cardiol; 2006 Mar; 25(3):273-92. PubMed ID: 16789402
[TBL] [Abstract][Full Text] [Related]
22. Treating hypertension. Are the right drugs given to the right patients?
Beaulieu MD; Dufresne L; LeBlanc D
Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
[TBL] [Abstract][Full Text] [Related]
23. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.
Siegel D; Lopez J
JAMA; 1997 Dec; 278(21):1745-8. PubMed ID: 9388150
[TBL] [Abstract][Full Text] [Related]
24. Seventeen-Year Nationwide Trends in Antihypertensive Drug Use in Denmark.
Sundbøll J; Adelborg K; Mansfield KE; Tomlinson LA; Schmidt M
Am J Cardiol; 2017 Dec; 120(12):2193-2200. PubMed ID: 29054274
[TBL] [Abstract][Full Text] [Related]
25. General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies.
Buusman A; Kragstrup J; Andersen M
Eur J Clin Pharmacol; 2005 Oct; 61(9):651-6. PubMed ID: 16187132
[TBL] [Abstract][Full Text] [Related]
26. HOPE study impact on ACE inhibitors use.
Hemels ME; Bennett HA; Bonari L; Han D; Traverso ML; Einarson TR
Ann Pharmacother; 2003 May; 37(5):640-5. PubMed ID: 12708937
[TBL] [Abstract][Full Text] [Related]
27. [Population analysis by area of health of changes in consumption, price and expenditure of cardiovascular drugs in eight autonomous communities, Spain, 2005].
Sanfélix-Gimeno G; Peiró S; Librero J; Ausejo-Segura M; Suárez-Alemán C; Molina-López T; Concepción CM; Castaño-Riera E;
Rev Esp Salud Publica; 2010; 84(4):389-407. PubMed ID: 21141266
[TBL] [Abstract][Full Text] [Related]
28. [Rational prescribing and cost reduction in the treatment of arterial hypertension: a simulation exercise].
Bonet A; Gosalbes V; Fito M; Navarro J
Gac Sanit; 2001; 15(4):327-35. PubMed ID: 11578562
[TBL] [Abstract][Full Text] [Related]
29. Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs.
Donohue JM; Fischer MA; Huskamp HA; Weissman JS
Health Serv Res; 2008 Oct; 43(5 Pt 1):1557-75. PubMed ID: 18479406
[TBL] [Abstract][Full Text] [Related]
30. [Comparisons outpatient drug prescriptions: France, Denmark, Norway, Sweden].
Dezileaux B; Martinez F
Therapie; 2016 Jun; 71(3):297-305. PubMed ID: 27235653
[TBL] [Abstract][Full Text] [Related]
31. Patterns in drug utilization--national and international aspects: antihypertensive drugs.
Baksaas I
Acta Med Scand Suppl; 1984; 683():59-66. PubMed ID: 6146249
[TBL] [Abstract][Full Text] [Related]
32. Method of estimating the disposition of drugs in the Danish population by sampling reimbursed prescriptions.
Andreasen F; Bech A; Behrendt F; Madsen H; Moustgaard L; Nielsen M
Eur J Clin Pharmacol; 1979 Nov; 16(5):361-7. PubMed ID: 520405
[TBL] [Abstract][Full Text] [Related]
33. Effects of cardiovascular disease on pharmacokinetics.
Rodighiero V
Cardiovasc Drugs Ther; 1989 Oct; 3(5):711-30. PubMed ID: 2577313
[TBL] [Abstract][Full Text] [Related]
34. Pricing and costs of drugs in the United States and Sweden: a comparison based on drug acquisition costs at the patient outcome level.
Melander A; Nilsson JL
J Ambul Care Manage; 2004; 27(2):115-9. PubMed ID: 15069988
[TBL] [Abstract][Full Text] [Related]
35. Changes in drug treatment in the elderly between 1971 and 2000.
Lernfelt B; Samuelsson O; Skoog I; Landahl S
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):637-44. PubMed ID: 12923602
[TBL] [Abstract][Full Text] [Related]
36. Correlation of drug utilisation and morbidity at the municipality level. High use of antibiotics associated with low use of antihypertensives.
Nilsson JL; Lindberg G; Johansson H; Melander A
Eur J Clin Pharmacol; 2006 Aug; 62(8):675-80. PubMed ID: 16823583
[TBL] [Abstract][Full Text] [Related]
37. [Consumption of antacids and anticholinergic agents in Denmark. Relation to altered rules for subsidizing medicines].
Koster A; Mosbech J
Ugeskr Laeger; 1977 Mar; 139(12):710-1. PubMed ID: 847801
[No Abstract] [Full Text] [Related]
38. Rational use of medications: if Canada can't do it ..
Califf RM
CMAJ; 2009 Jul; 181(1-2):15-6. PubMed ID: 19581612
[No Abstract] [Full Text] [Related]
39. Twenty-Three-Year Trends in the Use of Potentially Nephrotoxic Drugs in Denmark.
Enevoldsen FC; Christiansen CF; Jensen SK
Clin Epidemiol; 2023; 15():275-287. PubMed ID: 36915868
[TBL] [Abstract][Full Text] [Related]
40. [Consumption of drugs: policies and social pact].
Antoñanzas Villar F
Gac Sanit; 2000; 14(2):93-6. PubMed ID: 11203054
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
